Order Article Reprints

Labots M, Pham TV, Honeywell RJ, Knol JC, Beekhof R, de Goeij-de Haas R, Dekker H, Neerincx M, Piersma SR, van der Mijn JC, et al. Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome. Cancers. 2020; 12(2):330. https://doi.org/10.3390/cancers12020330

Labots, Mariette, Thang V. Pham, Richard J. Honeywell, Jaco C. Knol, Robin Beekhof, Richard de Goeij-de Haas, Henk Dekker, Maarten Neerincx, Sander R. Piersma, Johannes C. van der Mijn, and et al. 2020. "Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome" Cancers 12, no. 2: 330. https://doi.org/10.3390/cancers12020330

Labots, M., Pham, T. V., Honeywell, R. J., Knol, J. C., Beekhof, R., de Goeij-de Haas, R., Dekker, H., Neerincx, M., Piersma, S. R., van der Mijn, J. C., van der Peet, D. L., Meijerink, M. R., Peters, G. J., van Grieken, N. C. T., Jiménez, C. R., & Verheul, H. M. W. (2020). Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome. Cancers, 12(2), 330. https://doi.org/10.3390/cancers12020330